Blood Transfusion Reactions for NCLEX: A Safety Incident Review

The incident report begins with a unit of red blood cells, new chills, and a falling blood pressure. It should not begin with an assumption that the patient merely needs an antipyretic.

For blood transfusion reactions on the NCLEX, the first decision is a safety decision: recognize a possible reaction, stop the transfusion, assess the patient, and obtain appropriate help. Identifying the exact reaction follows urgent assessment and investigation.

The incident: Symptoms during a red-cell transfusion

In this original fictional event, an adult receiving red cells for anemia after gastrointestinal bleeding had a pretransfusion temperature of 36.8°C, heart rate of 86/min, and blood pressure of 122/70 mm Hg. During the transfusion, the patient develops chills, back pain, and a temperature of 38.2°C. Blood pressure is now 88/50 mm Hg.

The RN stops the transfusion immediately, assesses airway, breathing, circulation, and vital signs, and activates urgent assistance for hypotension and suspected reaction. The clinical team and transfusion service are notified. The patient is not left alone while someone searches for a reaction form.

The blood component and tubing are retained for investigation according to policy. The nurse maintains IV access using the appropriate new tubing or separate line and compatible fluid as directed by local procedures. Do not flush residual blood from the existing transfusion line into the patient. Normal saline is commonly used to maintain access, but the exact setup follows the facility's procedure.

The first investigation is about the patient and the product

Repeat the bedside identity and clerical checks. Compare the patient's identifiers, wristband, component label, compatibility information, and orders using the required process. Check the component for unexpected appearance, without assuming that a normal-looking bag proves safety.

In the fictional audit, the bag and its accompanying paperwork had been compared with each other, but the active bedside check against the patient's identity had been bypassed. The recipient identifier on the component did not match the patient's wristband.

That is a serious identification failure and supports immediate concern for incompatible transfusion. It does not prove every laboratory feature of an acute hemolytic reaction. The blood bank and clinical team investigate compatibility, hemolysis, possible infection, and other causes while managing the patient's condition.

The lesson is specific: matching two documents is not equivalent to confirming that the right component is being given to the right patient. Required independent or electronic verification processes must be performed at the appropriate point of care.

Why “fever means febrile nonhemolytic” is unsafe

A febrile nonhemolytic transfusion reaction can cause fever or chills. However, fever during transfusion can also accompany acute hemolysis or bacterial contamination. Hypotension and pain in this case make a casual “mild fever” interpretation especially unsafe.

Acute hemolytic reactions involve destruction of transfused red cells and may cause fever, chills, back or flank pain, hypotension, hemoglobinuria, kidney injury, or coagulopathy. Not every finding must be present. Incompatibility is one important concern, and laboratory evaluation is needed.

A contaminated component can produce fever, rigors, and circulatory collapse. Evaluation may include cultures from the patient and component through the appropriate team and laboratory process. The nurse preserves the product and communicates promptly rather than discarding the evidence.

For these reasons, febrile nonhemolytic reaction is a diagnosis of exclusion. Giving an antipyretic and continuing the transfusion without assessment can conceal progression of a more serious event.

Different symptoms lead to different investigations

Hives alone versus a systemic allergic emergency

Isolated itching or urticaria differs from new airway swelling, wheezing, hypotension, or other systemic signs suggesting anaphylaxis. Both require a prompt assessment and interruption of the transfusion while the response is determined. The systemic pattern calls for emergency management according to the facility's protocol.

Do not independently restart a transfusion because a rash appears mild. Some policies allow a carefully evaluated, resolved minor reaction to be restarted after appropriate clinical authorization. That is different from restarting a component implicated in a serious reaction. The RN follows the specific medical and transfusion-service direction.

New respiratory distress: TACO is not TRALI

Transfusion-associated circulatory overload, or TACO, involves hydrostatic pulmonary edema associated with circulatory overload. Findings may include respiratory distress, evidence of fluid overload, and cardiovascular changes. Patient vulnerability, transfused volume, and infusion rate matter.

Transfusion-related acute lung injury, or TRALI, involves acute lung injury with hypoxemia and pulmonary edema that is not primarily explained by circulatory overload. Distinguishing the two requires the complete clinical assessment, imaging, and investigations; one blood pressure reading or the presence of fever cannot reliably settle it.

The CDC's 2026 hemovigilance definitions use a window of up to 12 hours after transfusion cessation for TACO and within 6 hours for TRALI. These are surveillance definitions, not instructions to wait before responding or a guarantee that all later breathing problems are unrelated.

The initial nursing response to new respiratory distress remains urgent: stop the transfusion, assess and support breathing, summon help, and notify the transfusion service. Subsequent treatment depends on the cause. Diuretics should not be assumed to treat every transfusion-associated respiratory event.

What should have been in place before the event?

Pretransfusion preparation includes the appropriate order, consent process, compatibility and component checks, positive patient identification, suitable access and administration equipment, and baseline assessment. Ask about previous reactions and relevant risks, such as conditions that may increase vulnerability to overload.

Explain symptoms the patient should report immediately, including chills, breathing difficulty, itching, pain, or feeling suddenly unwell. Observe and document according to the component and local policy, including the required close observation at initiation. A patient who cannot report symptoms needs particularly attentive assessment.

The correct rate, equipment, verification method, and observation intervals depend on the component and applicable institutional requirements. A single memorized “blood administration routine” should not be applied indiscriminately to every product and patient.

The documentation should explain the event, not assign a premature label

Record the component and identifiers, timing and amount administered, baseline and subsequent observations, the patient's symptoms, actions taken, clinicians and blood bank notified, specimens sent, and the response to treatment. Complete the required incident reporting without substituting it for the clinical record.

Relevant laboratory results help investigate hemolysis, kidney function, infection, or coagulation problems. The NCLEX lab values article develops that interpretation skill. In a bleeding patient, the need for blood replacement does not remove the obligation to stop and assess a suspected reaction. The prioritization guide explains how new instability changes the order of nursing actions.

For the incident described here, the safety failure was bypassing positive patient identification. The clinical error to avoid is different: deciding that fever is harmless before investigating the associated hypotension and pain. An answer can recognize both problems without claiming a definitive diagnosis before the workup is complete.

Evidence used

This fictional incident is an educational analysis. Actual emergency actions and any decision about further transfusion follow local policy and the treating and transfusion-service teams.

• AABB and collaborating organizations: Circular of Information for the Use of Human Blood and Blood Components, June 2024 edition, current edition listed at review.
• CDC NHSN Hemovigilance Module Surveillance Protocol, version 3.0, 2026.
• CDC: Clinical guidance for bacterial contamination and blood safety.
• Australian Red Cross Lifeblood: Management of suspected reactions, used for clinical safety principles, not as U.S. regulation.